RIVASTIGMINE

RIVASTIGMINE was reported 19010 times

RIVASTIGMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MINI MENTAL STATUS EXAMINATION ABNORMAL 14 0.1707
1 MEDICAL DEVICE SITE DRYNESS 10 0.1538
2 VASCULAR ENCEPHALOPATHY 30 0.1056
3 URINARY CASTS PRESENT 11 0.1048
4 TOBACCO INTERACTION 11 0.0991
5 BLOOD CHOLINESTERASE DECREASED 27 0.0985
6 DEMENTIA ALZHEIMER'S TYPE 160 0.0958
7 STOMA SITE DISCOMFORT 21 0.0925
8 STOMA SITE INDURATION 11 0.0924
9 STOMA SITE REACTION 57 0.0832
10 STOMA SITE ERYTHEMA 146 0.0781
11 STOMA SITE DISCHARGE 191 0.0697
12 FREEZING PHENOMENON 257 0.0693
13 ON AND OFF PHENOMENON 381 0.0686
14 STOMA SITE ODOUR 15 0.0670
15 STOMA SITE IRRITATION 35 0.0643
16 DEMENTIA WITH LEWY BODIES 70 0.0629
17 STOMA SITE HYPERGRANULATION 38 0.0602
18 FIBROMA 55 0.0598
19 STOMA SITE INFLAMMATION 44 0.0589
20 AGNOSIA 14 0.0588
21 STOMA SITE EXTRAVASATION 22 0.0570
22 HYPERKINESIA 119 0.0561
23 ASPIRATION BRONCHIAL 16 0.0541
24 APPLICATION SITE HYPERSENSITIVITY 64 0.0527
25 CHOLINERGIC SYNDROME 31 0.0486
26 STOMA SITE PAIN 70 0.0476
27 EUTHANASIA 14 0.0442
28 ANTICHOLINERGIC SYNDROME 68 0.0427
29 REDUCED FACIAL EXPRESSION 43 0.0424
30 ENTERAL NUTRITION 23 0.0397
31 STOMA SITE INFECTION 51 0.0392
32 SENILE DEMENTIA 26 0.0390
33 BRADYKINESIA 221 0.0374
34 PARKINSONIAN GAIT 23 0.0369
35 AKINESIA 75 0.0362
36 PATIENT ELOPEMENT 11 0.0301
37 SUSPICIOUSNESS 21 0.0299
38 BASAL GANGLIA INFARCTION 10 0.0291
39 REPETITIVE SPEECH 16 0.0284
40 RESTING TREMOR 18 0.0279
41 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 28 0.0278
42 PLEUROTHOTONUS 25 0.0277
43 PARKINSON'S DISEASE 68 0.0267
44 FRONTOTEMPORAL DEMENTIA 11 0.0256
45 LACK OF SPONTANEOUS SPEECH 11 0.0251
46 MUSCLE RIGIDITY 295 0.0246
47 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 26 0.0242
48 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 10 0.0238
49 VASCULAR DEMENTIA 20 0.0228
50 STOMA SITE HAEMORRHAGE 33 0.0214
51 COGWHEEL RIGIDITY 22 0.0210
52 DEMENTIA 578 0.0207
53 GRIMACING 16 0.0205
54 CEREBELLAR ATROPHY 18 0.0204
55 DELUSION 316 0.0203
56 POSTURE ABNORMAL 66 0.0203
57 EYELID FUNCTION DISORDER 16 0.0202
58 SUBILEUS 42 0.0202
59 JOINT WARMTH 25 0.0200
60 HALLUCINATION 1478 0.0196
61 HALLUCINATION, VISUAL 413 0.0195
62 HALLUCINATION, TACTILE 13 0.0195
63 FOOD REFUSAL 17 0.0194
64 MEDICAL DEVICE CHANGE 10 0.0188
65 DEVICE ALARM ISSUE 31 0.0171
66 STOMA COMPLICATION 17 0.0167
67 COMPULSIONS 11 0.0165
68 ESCHAR 12 0.0164
69 NEURODEGENERATIVE DISORDER 10 0.0162
70 POLYPECTOMY 12 0.0150
71 THERAPEUTIC PRODUCT EFFECT VARIABLE 58 0.0149
72 DAYDREAMING 23 0.0149
73 PSYCHOTIC BEHAVIOUR 15 0.0148
74 HALLUCINATIONS, MIXED 62 0.0147
75 BLADDER CATHETERISATION 14 0.0144
76 DEVICE CONNECTION ISSUE 30 0.0142
77 APRAXIA 21 0.0142
78 HYPORESPONSIVE TO STIMULI 16 0.0136
79 CEREBRAL ATROPHY 54 0.0135
80 DELUSIONAL DISORDER, UNSPECIFIED TYPE 10 0.0134
81 ILLUSION 22 0.0133
82 APPLICATION SITE DERMATITIS 12 0.0128
83 PARKINSONISM 124 0.0127
84 SPUTUM INCREASED 27 0.0125
85 DYSCHEZIA 38 0.0124
86 DIET REFUSAL 9 0.0123
87 COMMUNICATION DISORDER 45 0.0118
88 REHABILITATION THERAPY 44 0.0114
89 DYSKINESIA 456 0.0112
90 FLUID INTAKE REDUCED 56 0.0112
91 HYPERSEXUALITY 20 0.0109
92 INFUSION SITE INDURATION 16 0.0108
93 AGGRESSION 532 0.0106
94 SLEEP TALKING 18 0.0106
95 TENSION 64 0.0105
96 APPLICATION SITE ERYTHEMA 274 0.0104
97 INFUSION SITE NODULE 10 0.0104
98 NONSPECIFIC REACTION 57 0.0104
99 INFARCTION 70 0.0102
100 COGNITIVE DISORDER 476 0.0102
101 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11 0.0100
102 FAECALOMA 54 0.0098
103 SALIVARY HYPERSECRETION 98 0.0098
104 GASTROSTOMY 15 0.0097
105 DYSENTERY 18 0.0097
106 INFREQUENT BOWEL MOVEMENTS 24 0.0096
107 SICK SINUS SYNDROME 11 0.0096
108 ABNORMAL BEHAVIOUR 375 0.0095
109 CLAVICLE FRACTURE 36 0.0094
110 APPLICATION SITE INFLAMMATION 13 0.0094
111 DELIRIUM 322 0.0093
112 TERMINAL STATE 62 0.0093
113 SCREAMING 59 0.0093
114 INCOHERENT 59 0.0091
115 DEVICE KINK 33 0.0090
116 FEMORAL NECK FRACTURE 46 0.0090
117 ORTHOSTATIC HYPOTENSION 156 0.0089
118 DISORIENTATION 355 0.0089
119 SINUS ARREST 14 0.0089
120 BLOOD SODIUM INCREASED 24 0.0089
121 HYPOKINESIA 128 0.0088
122 DECUBITUS ULCER 71 0.0087
123 CONCOMITANT DISEASE PROGRESSION 17 0.0087
124 APPLICATION SITE PRURITUS 197 0.0087
125 NOSOCOMIAL INFECTION 19 0.0086
126 TORTICOLLIS 18 0.0085
127 PRODUCT ADHESION ISSUE 299 0.0084
128 APPARENT DEATH 30 0.0083
129 PARANOIA 142 0.0082
130 CONFUSIONAL STATE 1331 0.0082
131 MOTOR DYSFUNCTION 81 0.0079
132 VITAMIN B12 DEFICIENCY 32 0.0079
133 PALLIATIVE CARE 12 0.0078
134 PSYCHOTIC SYMPTOM 16 0.0077
135 SLOW RESPONSE TO STIMULI 10 0.0077
136 APPLICATION SITE RASH 106 0.0077
137 RESTLESSNESS 281 0.0077
138 LOGORRHOEA 27 0.0077
139 FINE MOTOR SKILL DYSFUNCTION 22 0.0076
140 PNEUMONIA ASPIRATION 189 0.0076
141 AGITATION 552 0.0075
142 ASPIRATION 82 0.0075
143 LIVING IN RESIDENTIAL INSTITUTION 14 0.0075
144 WHITE BLOOD CELLS URINE POSITIVE 14 0.0074
145 WHEELCHAIR USER 33 0.0074
146 LANGUAGE DISORDER 16 0.0074
147 BRONCHOPNEUMONIA 25 0.0073
148 IMPAIRED SELF-CARE 15 0.0072
149 FACIAL BONES FRACTURE 26 0.0072
150 HYPOPHAGIA 182 0.0071
151 DROOLING 48 0.0069
152 FAECES HARD 27 0.0069
153 SPEECH DISORDER 363 0.0069
154 CARDIOACTIVE DRUG LEVEL INCREASED 9 0.0068
155 DISINHIBITION 11 0.0068
156 IMPULSE-CONTROL DISORDER 14 0.0068
157 DEVICE OCCLUSION 94 0.0067
158 CATATONIA 35 0.0067
159 GASTROINTESTINAL SOUNDS ABNORMAL 33 0.0067
160 ATRIOVENTRICULAR BLOCK SECOND DEGREE 20 0.0066
161 SINUS BRADYCARDIA 63 0.0065
162 IMMOBILE 28 0.0064
163 GASTROINTESTINAL TUBE INSERTION 16 0.0064
164 DYSTONIA 123 0.0063
165 BEHAVIOUR DISORDER 34 0.0063
166 APPLICATION SITE REACTION 44 0.0063
167 INCORRECT DOSE ADMINISTERED BY PRODUCT 10 0.0062
168 ABDOMINAL TENDERNESS 31 0.0062
169 HIP FRACTURE 200 0.0062
170 BEDRIDDEN 81 0.0062
171 UNDERWEIGHT 12 0.0061
172 INCONTINENCE 64 0.0060
173 FAECAL INCONTINENCE 29 0.0060
174 PSYCHOMOTOR HYPERACTIVITY 100 0.0060
175 HYPERNATRAEMIA 30 0.0060
176 APPLICATION SITE SWELLING 30 0.0060
177 MIOSIS 48 0.0060
178 PARADOXICAL DRUG REACTION 22 0.0060
179 NOCTURIA 72 0.0059
180 LIBIDO INCREASED 12 0.0059
181 MUSCLE CONTRACTURE 12 0.0059
182 PRODUCT SUPPLY ISSUE 42 0.0059
183 PARESIS 13 0.0058
184 CONCOMITANT DISEASE AGGRAVATED 36 0.0058
185 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17 0.0058
186 UNRESPONSIVE TO STIMULI 148 0.0057
187 APHASIA 173 0.0057
188 URINARY INCONTINENCE 168 0.0057
189 RHINITIS ALLERGIC 25 0.0056
190 PERSECUTORY DELUSION 14 0.0056
191 STUPOR 18 0.0056
192 LABYRINTHITIS 14 0.0055
193 ABNORMAL DREAMS 152 0.0055
194 CLONUS 15 0.0055
195 BRADYARRHYTHMIA 9 0.0055
196 ATRIOVENTRICULAR BLOCK 42 0.0054
197 CYTOLYTIC HEPATITIS 18 0.0054
198 HANGOVER 19 0.0054
199 NEUROLEPTIC MALIGNANT SYNDROME 64 0.0054
200 SPINAL COLUMN INJURY 12 0.0054
201 FALL 1792 0.0054
202 PSYCHOTIC DISORDER 159 0.0054
203 PRODUCT RESIDUE PRESENT 29 0.0054
204 ABNORMAL FAECES 44 0.0054
205 APPLICATION SITE IRRITATION 66 0.0053
206 ABASIA 131 0.0053
207 CRANIOCEREBRAL INJURY 16 0.0053
208 BRADYCARDIA 280 0.0053
209 GENERAL PHYSICAL HEALTH DETERIORATION 580 0.0050
210 ANAL INCONTINENCE 45 0.0050
211 SLOW SPEECH 12 0.0049
212 APPLICATION SITE VESICLES 32 0.0049
213 APPLICATION SITE DISCOLOURATION 20 0.0049
214 MOBILITY DECREASED 352 0.0049
215 NASAL POLYPS 24 0.0049
216 CEREBRAL ISCHAEMIA 25 0.0049
217 APATHY 70 0.0048
218 DYSSTASIA 140 0.0048
219 APHAGIA 23 0.0048
220 WALKING DISABILITY 10 0.0048
221 POTENTIATING DRUG INTERACTION 16 0.0048
222 DYSPHAGIA 450 0.0047
223 MALNUTRITION 53 0.0047
224 INFUSION SITE INFECTION 11 0.0047
225 HEPATIC NEOPLASM MALIGNANT 10 0.0047
226 HEAD INJURY 149 0.0047
227 EATING DISORDER 99 0.0046
228 VOLVULUS 11 0.0046
229 ATROPHY 9 0.0046
230 BRADYPHRENIA 30 0.0046
231 BOWEL MOVEMENT IRREGULARITY 35 0.0046
232 HYPERSOMNIA 131 0.0046
233 STARING 11 0.0045
234 OBSESSIVE-COMPULSIVE DISORDER 36 0.0045
235 HALLUCINATION, AUDITORY 71 0.0045
236 CEREBRAL HAEMATOMA 15 0.0045
237 CORONARY ARTERY THROMBOSIS 9 0.0045
238 DIZZINESS POSTURAL 43 0.0044
239 APPETITE DISORDER 29 0.0044
240 MEMORY IMPAIRMENT 599 0.0044
241 FEMUR FRACTURE 135 0.0044
242 EXCORIATION 11 0.0043
243 ATRIOVENTRICULAR BLOCK COMPLETE 29 0.0043
244 INCREASED BRONCHIAL SECRETION 11 0.0043
245 GAIT INABILITY 143 0.0043
246 CACHEXIA 22 0.0043
247 HIP SURGERY 23 0.0042
248 LISTLESS 14 0.0042
249 BUNDLE BRANCH BLOCK LEFT 18 0.0042
250 OXYGEN SATURATION ABNORMAL 12 0.0042
251 ANAEMIA MACROCYTIC 9 0.0042
252 HEMIPLEGIA 35 0.0042
253 CATHETER SITE ERYTHEMA 9 0.0042
254 CHOKING 82 0.0042
255 PSYCHOMOTOR SKILLS IMPAIRED 11 0.0042
256 LACUNAR INFARCTION 10 0.0042
257 PEMPHIGOID 31 0.0041
258 PROSTATOMEGALY 16 0.0041
259 CARDIAC PACEMAKER INSERTION 24 0.0040
260 SKIN ABRASION 19 0.0040
261 SYNCOPE 402 0.0040
262 CREATININE RENAL CLEARANCE DECREASED 16 0.0040
263 WRONG PRODUCT ADMINISTERED 27 0.0040
264 MOVEMENT DISORDER 128 0.0040
265 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
266 FEEDING DISORDER 80 0.0039
267 DIABETIC COMPLICATION 10 0.0039
268 GAIT DISTURBANCE 751 0.0039
269 MASTICATION DISORDER 12 0.0039
270 DEVICE DISLOCATION 170 0.0039
271 MIDDLE INSOMNIA 73 0.0039
272 INITIAL INSOMNIA 40 0.0039
273 CEREBRAL THROMBOSIS 11 0.0039
274 BALANCE DISORDER 335 0.0039
275 DERMATITIS BULLOUS 28 0.0039
276 PELVIC FRACTURE 30 0.0038
277 HOSPICE CARE 38 0.0038
278 CARDIOPULMONARY FAILURE 15 0.0038
279 URINARY TRACT INFECTION 653 0.0038
280 MULTI-ORGAN FAILURE 66 0.0038
281 URINARY RETENTION 124 0.0037
282 HAEMORRHAGIC STROKE 29 0.0037
283 ILEUS 46 0.0037
284 ISCHAEMIA 17 0.0037
285 INFUSION SITE REACTION 11 0.0037
286 TREMOR 608 0.0037
287 FAILURE TO THRIVE 19 0.0037
288 PRESCRIBED UNDERDOSE 73 0.0037
289 BLADDER DISORDER 36 0.0036
290 ACCIDENTAL EXPOSURE 15 0.0036
291 PANIC REACTION 26 0.0036
292 MEDICAL DEVICE DISCOMFORT 11 0.0036
293 EMBEDDED DEVICE 35 0.0035
294 MYOCLONUS 42 0.0035
295 THERAPEUTIC PRODUCT EFFECT DELAYED 16 0.0035
296 WOUND COMPLICATION 12 0.0035
297 SUBDURAL HAEMATOMA 50 0.0035
298 ANOREXIA 45 0.0035
299 DEPRESSED LEVEL OF CONSCIOUSNESS 138 0.0035
300 CIRCULATORY COLLAPSE 59 0.0035
301 POLYMYALGIA RHEUMATICA 11 0.0035
302 SOMNOLENCE 693 0.0034
303 ELECTROCARDIOGRAM ABNORMAL 27 0.0034
304 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
305 CARDIO-RESPIRATORY ARREST 143 0.0034
306 MUSCLE CONTRACTIONS INVOLUNTARY 12 0.0034
307 NIGHTMARE 118 0.0034
308 SEDATION 88 0.0034
309 DERMATITIS CONTACT 38 0.0033
310 PETIT MAL EPILEPSY 17 0.0033
311 HUMERUS FRACTURE 16 0.0033
312 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 159 0.0033
313 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
314 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
315 FOOD INTOLERANCE 12 0.0033
316 GENERAL PHYSICAL CONDITION ABNORMAL 22 0.0032
317 TRANSIENT ISCHAEMIC ATTACK 108 0.0032
318 SOMNAMBULISM 21 0.0032
319 PALLOR 86 0.0032
320 HYDROCEPHALUS 17 0.0031
321 DUODENAL ULCER 22 0.0031
322 SOCIAL AVOIDANT BEHAVIOUR 18 0.0031
323 HYPOTONIA 31 0.0031
324 MENTAL IMPAIRMENT 75 0.0031
325 DISTURBANCE IN ATTENTION 165 0.0031
326 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
327 ALTERED STATE OF CONSCIOUSNESS 66 0.0030
328 SUSPECTED COVID-19 10 0.0030
329 RIB FRACTURE 62 0.0030
330 BLOOD PRESSURE FLUCTUATION 72 0.0030
331 HAEMATEMESIS 76 0.0030
332 DYSARTHRIA 112 0.0030
333 POOR QUALITY SLEEP 64 0.0030
334 ENURESIS 12 0.0030
335 HYPERTENSIVE CRISIS 33 0.0030
336 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
337 HYPERVENTILATION 17 0.0029
338 RALES 17 0.0029
339 MICTURITION DISORDER 10 0.0029
340 LOSS OF CONSCIOUSNESS 369 0.0029
341 DEFAECATION URGENCY 20 0.0029
342 EPILEPSY 87 0.0028
343 PANIC DISORDER 11 0.0028
344 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
345 HYPERTONIA 16 0.0028
346 DEVICE PLACEMENT ISSUE 10 0.0028
347 EXTRAPYRAMIDAL DISORDER 69 0.0028
348 EYE MOVEMENT DISORDER 19 0.0028
349 MUSCULOSKELETAL STIFFNESS 243 0.0028
350 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
351 DEHYDRATION 369 0.0028
352 FEAR 74 0.0027
353 LYMPHOEDEMA 19 0.0027
354 SUDDEN DEATH 29 0.0027
355 CEREBRAL HAEMORRHAGE 98 0.0027
356 DYSGRAPHIA 18 0.0027
357 HAEMORRHAGIC ANAEMIA 12 0.0027
358 WRONG TECHNIQUE IN DRUG USAGE PROCESS 99 0.0027
359 DEATH 2339 0.0027
360 VARICOSE VEIN 14 0.0027
361 UROSEPSIS 25 0.0027
362 CEREBROVASCULAR ACCIDENT 456 0.0027
363 CARDIOMEGALY 33 0.0027
364 PARTIAL SEIZURES 14 0.0027
365 IMPULSIVE BEHAVIOUR 10 0.0027
366 ARRHYTHMIA 125 0.0026
367 BODY HEIGHT DECREASED 28 0.0026
368 GASTROINTESTINAL MOTILITY DISORDER 14 0.0026
369 SLEEP TERROR 11 0.0026
370 RESPIRATORY ARREST 71 0.0026
371 AMNESIA 166 0.0025
372 LOWER LIMB FRACTURE 49 0.0025
373 DRUG INTERACTION 403 0.0025
374 UNEVALUABLE EVENT 192 0.0025
375 TEMPERATURE INTOLERANCE 26 0.0025
376 CARDIAC ARREST 208 0.0025
377 PARALYSIS 36 0.0025
378 BLOOD UREA INCREASED 42 0.0025
379 INTERNATIONAL NORMALISED RATIO INCREASED 70 0.0025
380 COORDINATION ABNORMAL 34 0.0024
381 WALKING AID USER 16 0.0024
382 PRODUCT ADMINISTRATION ERROR 49 0.0024
383 WRIST FRACTURE 29 0.0024
384 AKATHISIA 33 0.0024
385 CEREBRAL INFARCTION 59 0.0024
386 HAND FRACTURE 17 0.0024
387 WHITE BLOOD CELL COUNT INCREASED 92 0.0024
388 INFUSION SITE ERYTHEMA 20 0.0024
389 FACE INJURY 9 0.0024
390 NEUTROPHIL COUNT INCREASED 24 0.0023
391 PURULENT DISCHARGE 10 0.0023
392 SLEEP DISORDER 165 0.0023
393 DEVICE ISSUE 209 0.0023
394 ACTIVITIES OF DAILY LIVING IMPAIRED 46 0.0023
395 LUNG INFECTION 36 0.0023
396 ANGER 78 0.0023
397 MENTAL STATUS CHANGES 64 0.0023
398 PSYCHIATRIC SYMPTOM 17 0.0023
399 SKIN LACERATION 25 0.0023
400 DYSPHEMIA 10 0.0023
401 GRAND MAL CONVULSION 21 0.0023
402 HYPOTHERMIA 23 0.0023
403 LEUKOCYTOSIS 41 0.0023
404 SOPOR 30 0.0023
405 GASTRIC ULCER 43 0.0023
406 CONVULSION 129 0.0023
407 THINKING ABNORMAL 42 0.0023
408 PNEUMONIA 728 0.0022
409 LETHARGY 129 0.0022
410 GASTROINTESTINAL INFECTION 20 0.0022
411 HYPONATRAEMIA 125 0.0022
412 VENTRICULAR EXTRASYSTOLES 23 0.0022
413 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157 0.0022
414 DECREASED APPETITE 512 0.0022
415 SKIN REACTION 31 0.0022
416 BLOOD PRESSURE DECREASED 146 0.0022
417 HEART RATE DECREASED 77 0.0022
418 ERYSIPELAS 11 0.0022
419 MANIA 36 0.0022
420 TOXIC SKIN ERUPTION 22 0.0022
421 JOINT DISLOCATION 23 0.0022
422 PROSTATIC DISORDER 12 0.0022
423 DRUG TOLERANCE 11 0.0022
424 C-REACTIVE PROTEIN INCREASED 79 0.0022
425 TORSADE DE POINTES 17 0.0022
426 GASTRIC ULCER HAEMORRHAGE 12 0.0022
427 HIATUS HERNIA 28 0.0022
428 NEPHROGENIC ANAEMIA 10 0.0022
429 WEIGHT DECREASED 602 0.0022
430 CONDITION AGGRAVATED 655 0.0022
431 DECREASED ACTIVITY 23 0.0021
432 RECTAL HAEMORRHAGE 91 0.0021
433 RESPIRATORY TRACT INFECTION 55 0.0021
434 COLD SWEAT 37 0.0021
435 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
436 BLOOD PRESSURE ABNORMAL 41 0.0021
437 HYPOTENSION 413 0.0021
438 APNOEA 16 0.0021
439 DEPRESSED MOOD 108 0.0020
440 STATUS EPILEPTICUS 23 0.0020
441 LOWER GASTROINTESTINAL HAEMORRHAGE 15 0.0020
442 HEMIPARESIS 34 0.0020
443 HAEMATOMA 52 0.0020
444 GASTROENTERITIS 29 0.0020
445 PRODUCT AVAILABILITY ISSUE 45 0.0020
446 GASTRITIS 52 0.0020
447 COMA 94 0.0020
448 PERIPHERAL COLDNESS 27 0.0020
449 CORONAVIRUS INFECTION 13 0.0020
450 MENTAL DISORDER 85 0.0020
451 APPLICATION SITE PAIN 43 0.0020
452 RESPIRATORY FAILURE 142 0.0019
453 VOMITING 914 0.0019
454 MITRAL VALVE INCOMPETENCE 22 0.0019
455 PURPURA 17 0.0019
456 ARTERIOSCLEROSIS 18 0.0019
457 GASTRIC HAEMORRHAGE 22 0.0019
458 UPPER LIMB FRACTURE 38 0.0019
459 INFUSION SITE SWELLING 12 0.0019
460 CARDIAC FAILURE 153 0.0019
461 UNINTENTIONAL MEDICAL DEVICE REMOVAL 22 0.0019
462 CYSTITIS 60 0.0019
463 RENAL FAILURE ACUTE 79 0.0019
464 CONSTIPATION 405 0.0019
465 CATARACT OPERATION 11 0.0019
466 PROTHROMBIN TIME PROLONGED 11 0.0018
467 RETCHING 39 0.0018
468 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
469 CRYING 66 0.0018
470 ANEURYSM 9 0.0018
471 LACERATION 17 0.0018
472 SCRATCH 19 0.0018
473 UPPER GASTROINTESTINAL HAEMORRHAGE 30 0.0018
474 NERVOUSNESS 93 0.0018
475 HEART RATE IRREGULAR 40 0.0018
476 REBOUND EFFECT 20 0.0018
477 MEDICATION ERROR 98 0.0018
478 MOOD ALTERED 48 0.0018
479 PERONEAL NERVE PALSY 10 0.0018
480 MUSCULAR WEAKNESS 200 0.0018
481 ATELECTASIS 17 0.0018
482 CEREBRAL DISORDER 13 0.0018
483 INSOMNIA 468 0.0018
484 SECRETION DISCHARGE 22 0.0018
485 HEAD DISCOMFORT 31 0.0017
486 IMPAIRED QUALITY OF LIFE 25 0.0017
487 PRESYNCOPE 42 0.0017
488 ELECTROCARDIOGRAM QT PROLONGED 62 0.0017
489 ASTHENIA 644 0.0017
490 HYPOVOLAEMIA 10 0.0017
491 HYPERTHERMIA 13 0.0017
492 URINE ODOUR ABNORMAL 10 0.0017
493 GASTROINTESTINAL HAEMORRHAGE 142 0.0017
494 UNDERDOSE 124 0.0017
495 LIPASE INCREASED 13 0.0017
496 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
497 FRACTURE 32 0.0017
498 EMBOLISM 14 0.0017
499 REFUSAL OF TREATMENT BY PATIENT 11 0.0017
500 POLLAKIURIA 70 0.0017
501 DERMATITIS ALLERGIC 21 0.0017
502 SLUGGISHNESS 17 0.0017
503 SKIN IRRITATION 76 0.0017
504 AFFECTIVE DISORDER 13 0.0017
505 WOUND 46 0.0016
506 DIZZINESS 820 0.0016
507 MELAENA 36 0.0016
508 ATRIAL FLUTTER 13 0.0016
509 BODY TEMPERATURE DECREASED 16 0.0016
510 FOOT DEFORMITY 18 0.0016
511 TACHYPNOEA 22 0.0016
512 PERSONALITY CHANGE 15 0.0016
513 FAECES DISCOLOURED 35 0.0016
514 HYPERHIDROSIS 207 0.0016
515 ACUTE PULMONARY OEDEMA 9 0.0016
516 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
517 HYPERKALAEMIA 56 0.0016
518 DRUG ADMINISTRATION ERROR 49 0.0016
519 RESTLESS LEGS SYNDROME 29 0.0016
520 JOINT INJURY 34 0.0016
521 CYANOSIS 25 0.0016
522 EMPHYSEMA 16 0.0016
523 HICCUPS 13 0.0016
524 PRODUCTIVE COUGH 75 0.0016
525 DRUG INTOLERANCE 151 0.0016
526 WOUND INFECTION 17 0.0016
527 ELECTROLYTE IMBALANCE 18 0.0015
528 MALAISE 679 0.0015
529 DEVICE USE ISSUE 27 0.0015
530 BLOOD SODIUM DECREASED 29 0.0015
531 OSTEOARTHRITIS 65 0.0015
532 HYPERTENSION 324 0.0015
533 DECREASED INTEREST 9 0.0015
534 FACIAL PARALYSIS 13 0.0015
535 MUSCLE TWITCHING 35 0.0015
536 PHOTOSENSITIVITY REACTION 25 0.0015
537 HAEMATOCRIT DECREASED 30 0.0015
538 BLOOD ALBUMIN DECREASED 12 0.0015
539 PRODUCT PRESCRIBING ERROR 36 0.0015
540 INTENTIONAL UNDERDOSE 11 0.0015
541 ATRIAL FIBRILLATION 146 0.0015
542 SPINAL FRACTURE 30 0.0015
543 MICTURITION URGENCY 17 0.0015
544 URINE OUTPUT DECREASED 13 0.0015
545 OEDEMA PERIPHERAL 179 0.0015
546 CHROMATURIA 33 0.0015
547 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
548 ISCHAEMIC STROKE 26 0.0015
549 SEXUAL DYSFUNCTION 17 0.0014
550 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
551 IRRITABILITY 87 0.0014
552 TROPONIN INCREASED 11 0.0014
553 AORTIC ANEURYSM 11 0.0014
554 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
555 HYPOGLYCAEMIA 70 0.0014
556 ACCIDENT 17 0.0014
557 ANXIETY 405 0.0014
558 PANCREATITIS 75 0.0014
559 APHTHOUS ULCER 11 0.0014
560 DIABETES MELLITUS 108 0.0014
561 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
562 IRON DEFICIENCY ANAEMIA 13 0.0014
563 LUNG DISORDER 69 0.0014
564 PRESCRIBED OVERDOSE 27 0.0014
565 RHABDOMYOLYSIS 58 0.0014
566 ULCER 22 0.0014
567 HYPERCALCAEMIA 17 0.0014
568 OESOPHAGITIS 15 0.0014
569 SEPSIS 153 0.0014
570 SENSORY DISTURBANCE 22 0.0014
571 LUNG INFILTRATION 12 0.0014
572 MUSCLE DISORDER 11 0.0014
573 DEPRESSION 308 0.0014
574 BRAIN OEDEMA 17 0.0013
575 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
576 THERAPEUTIC PRODUCT EFFECT DECREASED 60 0.0013
577 ACCIDENTAL OVERDOSE 49 0.0013
578 DEAFNESS 35 0.0013
579 GENERAL SYMPTOM 10 0.0013
580 DYSPHONIA 78 0.0013
581 SEIZURE 154 0.0013
582 SEPTIC SHOCK 58 0.0013
583 SPINAL COMPRESSION FRACTURE 11 0.0013
584 ACUTE MYOCARDIAL INFARCTION 39 0.0013
585 MOOD SWINGS 42 0.0013
586 FEELING ABNORMAL 315 0.0013
587 ANOSMIA 19 0.0013
588 RENAL FAILURE CHRONIC 10 0.0013
589 ACUTE RESPIRATORY FAILURE 25 0.0013
590 HYPOALBUMINAEMIA 10 0.0013
591 QUALITY OF LIFE DECREASED 17 0.0013
592 CARDIAC DISORDER 118 0.0013
593 RENAL CYST 10 0.0013
594 BLOOD CALCIUM INCREASED 11 0.0013
595 PULMONARY OEDEMA 56 0.0012
596 RENAL FAILURE 166 0.0012
597 BLOOD PRESSURE INCREASED 190 0.0012
598 GASTROINTESTINAL DISORDER 111 0.0012
599 LACTIC ACIDOSIS 40 0.0012
600 SCHIZOPHRENIA 15 0.0012
601 PULMONARY EMBOLISM 117 0.0012
602 SHOCK HAEMORRHAGIC 10 0.0012
603 ASPHYXIA 10 0.0012
604 ENCEPHALOPATHY 30 0.0012
605 NERVOUS SYSTEM DISORDER 38 0.0012
606 SKIN HAEMORRHAGE 18 0.0012
607 HEPATITIS 31 0.0012
608 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
609 EOSINOPHIL COUNT INCREASED 10 0.0012
610 CHOLESTASIS 23 0.0012
611 BLOOD POTASSIUM DECREASED 36 0.0012
612 BACK INJURY 13 0.0012
613 GASTRIC DISORDER 41 0.0012
614 BLOOD CREATININE INCREASED 78 0.0012
615 DIPLOPIA 31 0.0012
616 BLISTER 67 0.0012
617 CHOLELITHIASIS 39 0.0012
618 BLOOD IRON DECREASED 14 0.0012
619 HIP ARTHROPLASTY 18 0.0012
620 ANAEMIA 224 0.0012
621 DISSOCIATION 9 0.0012
622 MACULAR DEGENERATION 14 0.0012
623 RESPIRATORY DISORDER 35 0.0012
624 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
625 CONCUSSION 9 0.0012
626 CARDIAC MURMUR 10 0.0012
627 DIVERTICULITIS 32 0.0012
628 PYELONEPHRITIS 10 0.0012
629 SLEEP APNOEA SYNDROME 22 0.0012
630 DRUG PRESCRIBING ERROR 22 0.0011
631 COLON CANCER 17 0.0011
632 THERAPEUTIC RESPONSE UNEXPECTED 51 0.0011
633 VITAMIN D DEFICIENCY 11 0.0011
634 RESPIRATORY RATE INCREASED 10 0.0011
635 INFECTION 163 0.0011
636 INTESTINAL OBSTRUCTION 42 0.0011
637 DYSURIA 41 0.0011
638 PANCREATITIS ACUTE 25 0.0011
639 MYOCARDIAL INFARCTION 194 0.0011
640 BLOOD POTASSIUM INCREASED 18 0.0011
641 DEVICE BREAKAGE 45 0.0011
642 BLOOD URINE PRESENT 21 0.0011
643 LIMB INJURY 30 0.0011
644 BIPOLAR DISORDER 12 0.0011
645 MUSCULOSKELETAL DISORDER 21 0.0011
646 NAUSEA 869 0.0011
647 ACUTE CORONARY SYNDROME 9 0.0011
648 PRODUCT USE COMPLAINT 17 0.0011
649 EUPHORIC MOOD 11 0.0011
650 EMOTIONAL DISORDER 33 0.0011
651 KIDNEY INFECTION 21 0.0011
652 CONTUSION 103 0.0011
653 OXYGEN SATURATION DECREASED 60 0.0011
654 SKIN DISCOLOURATION 49 0.0011
655 CARDIOVASCULAR DISORDER 27 0.0011
656 SQUAMOUS CELL CARCINOMA 10 0.0011
657 CATARACT 63 0.0011
658 SPUTUM DISCOLOURED 10 0.0011
659 RENAL DISORDER 49 0.0011
660 WEIGHT FLUCTUATION 11 0.0011
661 RESPIRATORY DISTRESS 29 0.0010
662 DISEASE PROGRESSION 124 0.0010
663 ADVERSE DRUG REACTION 94 0.0010
664 JAUNDICE 28 0.0010
665 HYPOKALAEMIA 48 0.0010
666 POISONING 13 0.0010
667 LIMB DISCOMFORT 32 0.0010
668 VERTIGO 63 0.0010
669 DIARRHOEA 665 0.0010
670 ACUTE KIDNEY INJURY 157 0.0010
671 SKIN LESION 28 0.0010
672 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
673 HYPERGLYCAEMIA 37 0.0010
674 MYDRIASIS 13 0.0010
675 ATAXIA 12 0.0010
676 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
677 BLOOD GLUCOSE FLUCTUATION 11 0.0010
678 HAEMORRHAGE INTRACRANIAL 15 0.0010
679 ERYTHEMA 206 0.0010
680 TOOTH FRACTURE 11 0.0010
681 DEVICE DIFFICULT TO USE 66 0.0010
682 ABDOMINAL DISTENSION 104 0.0010
683 CARDIAC FAILURE CONGESTIVE 80 0.0010
684 SINUS TACHYCARDIA 14 0.0010
685 TASTE DISORDER 20 0.0010
686 ABDOMINAL PAIN 229 0.0010
687 HAEMOGLOBIN DECREASED 101 0.0010
688 ORAL PAIN 22 0.0010
689 PERIPHERAL SWELLING 151 0.0010
690 OSTEOPOROSIS 40 0.0010
691 VENTRICULAR TACHYCARDIA 16 0.0010
692 AGRANULOCYTOSIS 18 0.0010
693 MYELODYSPLASTIC SYNDROME 14 0.0010
694 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
695 HYPOXIA 34 0.0010
696 ERYTHEMA MULTIFORME 9 0.0010
697 DRUG TOXICITY 13 0.0010
698 MUSCLE ATROPHY 12 0.0009
699 DEVICE LEAKAGE 41 0.0009
700 TRANSAMINASES INCREASED 21 0.0009
701 PRODUCT DOSE OMISSION ISSUE 276 0.0009
702 BODY TEMPERATURE INCREASED 19 0.0009
703 CHOLECYSTITIS 11 0.0009
704 OSTEOPENIA 14 0.0009
705 DEVICE USE ERROR 32 0.0009
706 HYPERLIPIDAEMIA 11 0.0009
707 PLEURAL EFFUSION 56 0.0009
708 NODULE 12 0.0009
709 POLYNEUROPATHY 11 0.0009
710 HEPATOCELLULAR INJURY 13 0.0009
711 EOSINOPHILIA 16 0.0009
712 INFLAMMATION 47 0.0009
713 PULMONARY CONGESTION 12 0.0009
714 GASTROINTESTINAL PAIN 10 0.0009
715 HAEMATURIA 31 0.0009
716 PYREXIA 310 0.0009
717 PRODUCT PHYSICAL ISSUE 18 0.0009
718 TACHYCARDIA 79 0.0009
719 IMPAIRED GASTRIC EMPTYING 12 0.0009
720 CARDIOMYOPATHY 13 0.0009
721 HERNIA 17 0.0009
722 FATIGUE 683 0.0009
723 INTERNAL HAEMORRHAGE 10 0.0009
724 SHOCK 20 0.0009
725 MUSCLE SPASMS 159 0.0009
726 HYPOACUSIS 37 0.0009
727 DERMATITIS 18 0.0009
728 RASH MACULO-PAPULAR 19 0.0009
729 INFUSION SITE PAIN 11 0.0009
730 FLATULENCE 48 0.0008
731 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 171 0.0008
732 EPISTAXIS 63 0.0008
733 ABDOMINAL DISCOMFORT 141 0.0008
734 HAND DEFORMITY 11 0.0008
735 DRY MOUTH 68 0.0008
736 WITHDRAWAL SYNDROME 35 0.0008
737 TREATMENT NONCOMPLIANCE 45 0.0008
738 SCAR 14 0.0008
739 HAEMATOCHEZIA 45 0.0008
740 PRODUCT USE IN UNAPPROVED INDICATION 202 0.0008
741 FUNGAL INFECTION 27 0.0008
742 PRODUCT SUBSTITUTION ISSUE 46 0.0008
743 LYMPHOCYTE COUNT DECREASED 14 0.0008
744 MULTIPLE FRACTURES 13 0.0008
745 ILL-DEFINED DISORDER 48 0.0008
746 NECK PAIN 44 0.0008
747 INCREASED APPETITE 15 0.0008
748 GALLBLADDER DISORDER 14 0.0008
749 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
750 VIRAL INFECTION 26 0.0008
751 HOSPITALISATION 120 0.0008
752 GLAUCOMA 15 0.0008
753 OVERDOSE 167 0.0008
754 RASH MACULAR 27 0.0008
755 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
756 CARDIOGENIC SHOCK 11 0.0008
757 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
758 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
759 FEELING COLD 21 0.0008
760 BACTERIAL INFECTION 14 0.0007
761 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
762 JOINT RANGE OF MOTION DECREASED 10 0.0007
763 HEPATIC CIRRHOSIS 14 0.0007
764 BRONCHITIS 55 0.0007
765 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
766 COVID-19 130 0.0007
767 DYSPNOEA 419 0.0007
768 PRURITUS GENERALISED 16 0.0007
769 CHEST PAIN 137 0.0007
770 BACK DISORDER 12 0.0007
771 TOXICITY TO VARIOUS AGENTS 124 0.0007
772 DRUG INEFFECTIVE 968 0.0007
773 SURGERY 43 0.0007
774 PANCREATIC CARCINOMA 21 0.0007
775 DRUG LEVEL INCREASED 12 0.0007
776 DRUG DISPENSING ERROR 11 0.0007
777 STEVENS-JOHNSON SYNDROME 16 0.0007
778 NEPHROLITHIASIS 33 0.0007
779 EXTRA DOSE ADMINISTERED 29 0.0007
780 RASH PAPULAR 16 0.0007
781 MUSCULOSKELETAL CHEST PAIN 11 0.0007
782 ANKLE FRACTURE 11 0.0007
783 THROMBOSIS 57 0.0007
784 HYPERSENSITIVITY 131 0.0007
785 THERAPY PARTIAL RESPONDER 11 0.0007
786 ABDOMINAL PAIN UPPER 145 0.0007
787 FREQUENT BOWEL MOVEMENTS 19 0.0007
788 DYSPEPSIA 69 0.0007
789 OEDEMA 38 0.0007
790 ANGINA PECTORIS 20 0.0007
791 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
792 SKIN DISORDER 23 0.0007
793 PRODUCT DOSE OMISSION 45 0.0007
794 ILLNESS 71 0.0007
795 HYPOTHYROIDISM 22 0.0007
796 THROMBOCYTOPENIA 77 0.0007
797 FOOT FRACTURE 13 0.0007
798 PRODUCT USE ISSUE 128 0.0007
799 HAEMORRHAGE 71 0.0007
800 SEROTONIN SYNDROME 13 0.0007
801 CELLULITIS 34 0.0007
802 NEOPLASM MALIGNANT 45 0.0007
803 INJURY 47 0.0007
804 OSTEOMYELITIS 12 0.0007
805 CORONARY ARTERY DISEASE 20 0.0007
806 COAGULOPATHY 11 0.0007
807 OFF LABEL USE 577 0.0007
808 SKIN ULCER 17 0.0007
809 DISCOMFORT 40 0.0007
810 SUICIDAL IDEATION 60 0.0007
811 LIVER FUNCTION TEST ABNORMAL 19 0.0007
812 FACE OEDEMA 11 0.0007
813 DEVICE RELATED INFECTION 10 0.0006
814 RASH ERYTHEMATOUS 31 0.0006
815 PRURITUS 249 0.0006
816 BLOOD TEST ABNORMAL 9 0.0006
817 IMPAIRED HEALING 21 0.0006
818 LIVER DISORDER 28 0.0006
819 TINNITUS 29 0.0006
820 INCORRECT DOSE ADMINISTERED 144 0.0006
821 METABOLIC ACIDOSIS 20 0.0006
822 BLOOD CHOLESTEROL INCREASED 29 0.0006
823 DRUG ERUPTION 11 0.0006
824 ERUCTATION 12 0.0006
825 ALANINE AMINOTRANSFERASE INCREASED 38 0.0006
826 RASH GENERALISED 16 0.0006
827 PAIN IN EXTREMITY 182 0.0006
828 MUSCLE TIGHTNESS 10 0.0006
829 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
830 CHILLS 72 0.0006
831 VISUAL IMPAIRMENT 76 0.0006
832 ANGIOEDEMA 27 0.0006
833 GASTROENTERITIS VIRAL 11 0.0006
834 SWOLLEN TONGUE 19 0.0006
835 EYE DISORDER 20 0.0006
836 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
837 RENAL IMPAIRMENT 51 0.0006
838 SKIN CANCER 13 0.0006
839 BONE DISORDER 11 0.0006
840 PANIC ATTACK 22 0.0006
841 END STAGE RENAL DISEASE 11 0.0006
842 ECONOMIC PROBLEM 9 0.0006
843 FLUID RETENTION 30 0.0006
844 JOINT SWELLING 71 0.0006
845 RHINORRHOEA 38 0.0006
846 HEART RATE INCREASED 58 0.0006
847 DEEP VEIN THROMBOSIS 38 0.0006
848 INFLUENZA 65 0.0006
849 PERITONITIS 12 0.0006
850 NASAL CONGESTION 34 0.0006
851 FEELING JITTERY 11 0.0006
852 BASAL CELL CARCINOMA 9 0.0006
853 BACK PAIN 134 0.0006
854 WEIGHT INCREASED 129 0.0006
855 ASTHMA 65 0.0006
856 LOCAL SWELLING 10 0.0006
857 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
858 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102 0.0006
859 THERAPY CESSATION 29 0.0006
860 BLINDNESS 23 0.0006
861 TYPE 2 DIABETES MELLITUS 19 0.0006
862 HAEMORRHOIDS 11 0.0006
863 COUGH 158 0.0006
864 LACRIMATION INCREASED 17 0.0006
865 LEUKOPENIA 28 0.0006
866 THERAPY NON-RESPONDER 25 0.0006
867 COLITIS 21 0.0006
868 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
869 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
870 CONJUNCTIVITIS 10 0.0005
871 SWELLING FACE 35 0.0005
872 INTERSTITIAL LUNG DISEASE 26 0.0005
873 LUNG NEOPLASM MALIGNANT 22 0.0005
874 RASH 233 0.0005
875 ARTHRITIS 42 0.0005
876 NIGHT SWEATS 17 0.0005
877 RED BLOOD CELL COUNT DECREASED 15 0.0005
878 PULMONARY FIBROSIS 10 0.0005
879 AGEUSIA 13 0.0005
880 POST PROCEDURAL COMPLICATION 10 0.0005
881 PERICARDIAL EFFUSION 12 0.0005
882 PARAESTHESIA 81 0.0005
883 WHEEZING 30 0.0005
884 NASOPHARYNGITIS 92 0.0005
885 RASH PRURITIC 27 0.0005
886 NO ADVERSE EVENT 90 0.0005
887 LOCALISED INFECTION 12 0.0005
888 NEURALGIA 12 0.0005
889 HEADACHE 309 0.0005
890 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
891 PAIN 302 0.0005
892 SWELLING 46 0.0005
893 CHRONIC KIDNEY DISEASE 37 0.0005
894 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
895 TOOTH LOSS 10 0.0005
896 BLOOD BILIRUBIN INCREASED 13 0.0005
897 GASTRIC CANCER 12 0.0005
898 HERPES ZOSTER 27 0.0005
899 DRUG EFFECT INCOMPLETE 17 0.0005
900 INTENTIONAL OVERDOSE 30 0.0005
901 PRODUCT DISPENSING ERROR 10 0.0005
902 PRODUCT PRESCRIBING ISSUE 10 0.0005
903 ROAD TRAFFIC ACCIDENT 19 0.0005
904 TOOTH DISORDER 10 0.0004
905 HYPOAESTHESIA 66 0.0004
906 BLOOD GLUCOSE INCREASED 83 0.0004
907 MUSCULOSKELETAL PAIN 23 0.0004
908 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
909 HAEMOPTYSIS 12 0.0004
910 HEPATIC ENZYME INCREASED 29 0.0004
911 ECZEMA 22 0.0004
912 BLOOD GLUCOSE DECREASED 20 0.0004
913 SKIN EXFOLIATION 35 0.0004
914 BURNING SENSATION 29 0.0004
915 URTICARIA 69 0.0004
916 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
917 ARTHROPATHY 22 0.0004
918 STAPHYLOCOCCAL INFECTION 13 0.0004
919 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
920 CHEST DISCOMFORT 40 0.0004
921 DRUG RESISTANCE 10 0.0004
922 INTENTIONAL DOSE OMISSION 11 0.0004
923 DRUG-INDUCED LIVER INJURY 12 0.0004
924 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
925 THERAPEUTIC RESPONSE DECREASED 23 0.0004
926 THERAPY INTERRUPTED 27 0.0004
927 LABORATORY TEST ABNORMAL 11 0.0004
928 FIBROMYALGIA 9 0.0004
929 PALPITATIONS 43 0.0004
930 DRUG DOSE OMISSION 60 0.0004
931 VISUAL ACUITY REDUCED 12 0.0004
932 TARDIVE DYSKINESIA 10 0.0004
933 HEPATIC FUNCTION ABNORMAL 13 0.0003
934 PLATELET COUNT DECREASED 37 0.0003
935 PANCYTOPENIA 19 0.0003
936 RENAL INJURY 10 0.0003
937 VISION BLURRED 46 0.0003
938 MULTIPLE SCLEROSIS 16 0.0003
939 THROAT IRRITATION 15 0.0003
940 INFLUENZA LIKE ILLNESS 27 0.0003
941 FEELING HOT 20 0.0003
942 NEUROPATHY PERIPHERAL 31 0.0003
943 ARTHRALGIA 135 0.0003
944 DYSPNOEA EXERTIONAL 12 0.0003
945 ADVERSE EVENT 29 0.0003
946 DRY SKIN 42 0.0003
947 PROSTATE CANCER 25 0.0003
948 COMPLETED SUICIDE 25 0.0003
949 DRUG EFFECT DECREASED 16 0.0003
950 SUICIDE ATTEMPT 18 0.0003
951 OCULAR HYPERAEMIA 14 0.0003
952 MIGRAINE 28 0.0003
953 BONE PAIN 17 0.0003
954 EMOTIONAL DISTRESS 34 0.0003
955 PRODUCT QUALITY ISSUE 38 0.0003
956 INFUSION RELATED REACTION 18 0.0003
957 EXPIRED PRODUCT ADMINISTERED 9 0.0003
958 EYE SWELLING 10 0.0003
959 STOMATITIS 16 0.0003
960 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
961 BREAST CANCER 24 0.0003
962 DISEASE RECURRENCE 12 0.0003
963 INTENTIONAL PRODUCT MISUSE 21 0.0002
964 VAGINAL HAEMORRHAGE 10 0.0002
965 HOT FLUSH 17 0.0002
966 SINUSITIS 23 0.0002
967 COLITIS ULCERATIVE 10 0.0002
968 FLUSHING 22 0.0002
969 OROPHARYNGEAL PAIN 20 0.0002
970 DYSGEUSIA 16 0.0002
971 EYE PAIN 12 0.0002
972 MYALGIA 35 0.0002
973 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
974 TREATMENT FAILURE 17 0.0002
975 NEUTROPENIA 26 0.0002
976 ANAPHYLACTIC REACTION 10 0.0002
977 FEBRILE NEUTROPENIA 12 0.0002
978 BLADDER CANCER 10 0.0002
979 DEPENDENCE 9 0.0002
980 DRUG WITHDRAWAL SYNDROME 14 0.0002
981 SKIN BURNING SENSATION 11 0.0002
982 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
983 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
984 INJECTION SITE BRUISING 10 0.0001
985 INJECTION SITE HAEMORRHAGE 10 0.0001
986 DRUG ABUSE 10 0.0001
987 ALOPECIA 23 0.0001
988 DRUG DEPENDENCE 17 0.0001
989 RHEUMATOID ARTHRITIS 12 0.0001
990 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
991 INJECTION SITE PAIN 16 0.0001